Announce Date | 04/15/2025 |
EPS Normalized Actual | $-0.14 (Beat by $0.01) |
EPS GAAP Actual | $-0.14 (Beat by $0.01) |
Revenue Actual | $0.005955B |
Revenue Surprise | Beat by $5.955M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.08 |
EPS GAAP Estimate | $-0.08 |
Revenue Estimate | $0.0371B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | -0.13 | -2.19 | -0.14182 | -0.11223 | 1 |
Dec 2025 | -0.2 | -1.42 | -0.19991 | -0.20009 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2021 (Mar 2021) | -10.05 | -10.05 | 0.005955B | 100% | 5.96M |
FQ1 2025 (Mar 2025) | -0.1 | -0.02 | 0.009483B | -8.02% | -27.75M |
FQ4 2024 (Dec 2024) | -0.14 | -0.0475 | 0.01203B | -70.1% | -18.94M |
FQ3 2024 (Sep 2024) | -0.0003 | -0.0003 | 0.009943B | -97.17% | 9.94M |
FQ2 2024 (Jun 2024) | -0.14 | -0.14 | 0.017375B | 25.66% | 17.38M |
FQ2 2021 (Jun 2021) | 0 | 0 | 0B | NAN% | 0M |
FQ3 2021 (Sep 2021) | 0.025 | 0.025 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | -0.13 | -0.13 | 0.010244B | 100% | 10.24M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.08
Consensus Revenue Estimates
0.0371B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | -0.05 | -- | -0.0548467 | -0.04333457 | 0 |
FQ4 2026 (Oct 2026) | -0.06 | -- | -0.07250239 | -0.04903042 | 0 |
FQ3 2026 (Jul 2026) | -0.06 | -- | -0.07250239 | -0.04903042 | 0 |
FQ2 2026 (Jun 2026) | -0.03 | -- | -0.03649274 | -0.0231238 | 0 |
FQ1 2026 (Mar 2026) | -0.085 | -17.65 | -0.0932394 | -0.07366878 | 0 |
FQ4 2025 (Oct 2025) | -0.07 | -100 | -0.08458612 | -0.05720215 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 0.05B | -- | 0.05B | 0.05B | 1 |
FQ4 2026 (Oct 2026) | 0.05B | -- | 0.04B | 0.05B | 1 |
FQ3 2026 (Jul 2026) | 0.05B | -- | 0.04B | 0.05B | 1 |
FQ2 2026 (Jun 2026) | 0.05B | -- | 0.04B | 0.06B | 1 |
FQ1 2026 (Mar 2026) | 0.04B | 77.2 | 0.04B | 0.04B | 1 |
FQ4 2025 (Oct 2025) | 0.04B | 71.66 | 0.04B | 0.05B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
4
Revenue # of Misses
2
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2021 (Mar 2021) | -10.05 | -10.05 | 100% | |
FQ1 2025 (Mar 2025) | -0.08 | -0.1 | -0.02 | 20% |
FQ4 2024 (Dec 2024) | -0.0925 | -0.14 | -0.0475 | 33.93% |
FQ3 2024 (Sep 2024) | -0.0003 | -0.0003 | 100% | |
FQ2 2024 (Jun 2024) | -0.14 | -0.14 | 100% | |
FQ2 2021 (Jun 2021) | 0 | 0 | NAN% | |
FQ3 2021 (Sep 2021) | 0.025 | 0.025 | 100% | |
FQ1 2024 (Mar 2024) | -0.13 | -0.13 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2021 (Mar 2021) | $0B | $0.01B | $5.96M | 100% |
FQ1 2025 (Mar 2025) | $0.04B | $0.01B | $-27.75M | -292.6% |
FQ4 2024 (Dec 2024) | $0.03B | $0.01B | $-18.94M | -157.42% |
FQ3 2024 (Sep 2024) | $0B | $0.01B | $9.94M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.02B | $17.38M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $0.01B | $10.24M | 100% |